| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |